Yes — in 2026, all pregnancy testing before a first isotretinoin dose must still occur in a medical setting. Patients who can become pregnant must also pick up the drug within a 7-day window tied to testing. iPLEDGE, the Food and Drug Administration safety program for isotretinoin, enforces these safeguards against embryo-fetal exposure.
For parents, that means clinic visits and tight timing still shape the start. The National Community Pharmacists Association reports FDA approved iPLEDGE changes on Feb. 9, 2026, effective Aug. 9, 2026, to ease burden while keeping safeguards National Community Pharmacists Association notice.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What must happen before the first dose?
- Where does pretreatment testing have to occur?
- How does the 7-day pickup window work?
- What if your teen misses the window?
What must happen before the first dose?
Qualifying to start requires two negative urine or blood pregnancy tests before the first prescription. National Library of Medicine DailyMed labeling also calls for monthly negative tests before each refill and use of two contraception forms or abstinence.
Parents should treat both pretreatment tests as clinic appointments, not home kits or paperwork. Plan travel, school absence, and contraception counseling around them. The FDA contraception counseling guide states all patients, prescribers, and dispensing pharmacies must be enrolled and activated, so monthly compliance controls each fill.
- confirm the teen, prescriber, and dispensing pharmacy are enrolled and activated in iPLEDGE
- complete the first screening pregnancy test in a clinic or laboratory
- complete the second pretreatment pregnancy test in a clinic or laboratory
- record the contraception plan or abstinence and set the pickup date
Where does pretreatment testing have to occur?
All pretreatment pregnancy testing before the first dose must still occur in a medical setting. The FDA medical-organizations letter lists settings such as a prescriber office, clinic, or laboratory FDA medical-organizations letter. That start rule did not loosen with follow-up testing.
Dermatology Advisor reporting on FDA materials notes prescribers may now allow home tests during and after treatment, without the prior CLIA-certified-laboratory requirement. For access, do not buy a home test to begin treatment. Ask which office or lab performs the pretreatment tests, whether both need morning visits, and how results reach the prescriber.
How does the 7-day pickup window work?
Patients who can become pregnant must pick up isotretinoin within a 7-day prescription window tied to pregnancy testing. The Hospitalist summary of FDA advisory materials describes that window as still applied in 2026 The Hospitalist summary of FDA advisory materials. If pickup occurs after day seven, the prescription expires and retesting is required.
The clock links the negative test, the prescription, and the pharmacy handoff. A practical example helps. If testing occurs Monday, the family should know whether Monday counts as day one and which Sunday or Monday date closes the window. Confirm the exact pickup deadline before leaving the office.
What if your teen misses the window?
A missed window no longer triggers a long wait. The Journal of Dermatology for NPs/PAs reports FDA eliminated the 19-day lockout, so a repeat pregnancy test can occur immediately Journal of Dermatology for NPs/PAs report. When no dose has yet been taken, that repeat test occurs in a medical setting.
Parents should call the prescribing office promptly, reschedule testing, and reset the pickup plan. Keep iPLEDGE enrollment, test dates, and contraception answers current for every month. Ask the prescribing office how it logs iPLEDGE answers and test dates so each refill clears on the first call.
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Access and Prescription-Window Questions for Parents of Teens With Severe Acne
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: A Verification Checklist for Parents of Teens With Severe Acne
- Pediatric Acne and Rosacea at the 2026 AAD Annual Meeting: Treatment-Selection Questions for Parents of Teens With Acne